Skip to main content
. 2023 Nov 22;13:1294385. doi: 10.3389/fonc.2023.1294385

Table 1.

The patient’s laboratory test results.

2022/10/4 10/7 10/11 10/12 10/14 am 10/14 pm 10/15
WBC (×109/L) 6.17 5.71 10.95 10.04 12.52 14.69 17.07
ANC (×109/L) 5.2 4.93 9.98 9.08 11.23 15.15 13.16
PLT (×109/L) 162 125 125 137 187 217 113
Hb (g/L) 127 113 130 132 129 99 82
C-reactive protein (mg/L) 6.3 12.2 25.1 24.5 19.1 16.7
Total bilirubin (mmol/L) 129.8 165.6 280.7 316.9 345.8 194.1
Direct bilirubin (mmol/L) 89.8 119.2 195.6 219.6 245.3 144.4
Indirect bilirubin (mmol/L) 40 46.4 85.1 97.3 100.5 49.7
Total bile acid (mmol/L) 134 221.8 12.5
Albumin (g/L) 39.6 32.1 33.7 33.5 21.7 30.8 36.5
Alanine aminotransferase (U/L) 183 143 121 141 170
Aspartate amino transferase (U/L) 170 138 191 236 355
Alkaline phosphatase (U/L) 247 225 522 923 708
γ-Glutamyl transferase (IU/L) 715 544
Lactate dehydrogenase (U/L) 793 1415 42505
β2-Microglobulin (mg/L) 4.3 3.1 17.4 24.5
Urea (mmol/L) 5.18 3.32 10.09 16.76 26.24
Creatinine (mmol/L) 83.8 63.3 107.7 146.8 258.1
Prothrombin time (s) 13.6 32 46.4 48.1 71.3
Activated partial thromboplastin time (s) 28.4 42 48.7 54.4 65.5
INR 1.12 1.99 3.83 4.61 6.07
Thrombin time (s) 16.6 17.1 18.4 18.6 24.7
Fibrinogen (g/L) 2.97 2.91 2.87 2.65 1.05
Cancer antigen (CA) 19-9 (ng/mL) 235.43
Cancer antigen (CA) 72-4 (U/mL) 0.89
Cancer antigen (CA) 12-5 (U/mL) 44.1
Cancer antigen (CA) 15-3 (U/mL) 14.78
Ferritin (ng/mL) 336.9
Carcinoembryonic antigen (CEA) (ng/mL) 2.26
Alpha-fetoprotein (AFP) (ng/mL) 3.03

WBC, white blood cell; ANC, neutrophils; PLT, platelet; Hb, hemoglobin; INR, international normalized ratio.